Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Unknown × Oligometastatic Renal Cell Carcinoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 343 Breast Neoplasms 327 Colorectal Neoplasms 220 Stomach Neoplasms 195 Carcinoma, Hepatocellular 144 Lung Neoplasms 111 Neoplasms 109 Pancreatic Neoplasms 95 Prostatic Neoplasms 89 Ovarian Neoplasms 87 Recurrence 85 Rectal Neoplasms 84 Neoplasm Metastasis 84 Nasopharyngeal Carcinoma 82 Esophageal Squamous Cell Carcinoma 75 Lymphoma, Large B-Cell, Diffuse 72 Esophageal Neoplasms 71 Melanoma 70 Leukemia, Myeloid, Acute 68 Head and Neck Neoplasms 66 Lymphoma 65 Brain Neoplasms 64 Small Cell Lung Carcinoma 63 Squamous Cell Carcinoma of Head and Neck 62 Multiple Myeloma 62 Uterine Cervical Neoplasms 58 Sarcoma 58 Carcinoma, Renal Cell 58 Triple Negative Breast Neoplasms 53 Lymphoma, Non-Hodgkin 49

Interventions

pembrolizumab 1 Surgical Procedures, Operative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05578664 2023-08-30

PE-PE

Consorzio Oncotech

Phase 2 Unknown

Oligometastatic Renal Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡